Cochrane Hypertension
banner
cochranehtn.bsky.social
Cochrane Hypertension
@cochranehtn.bsky.social
740 followers 830 following 21 posts
Based @UBC, we prepare/maintain/disseminate #SysRevs of effects of healthcare interventions for high blood pressure. hypertension.cochrane.org Newsltr: http://eepurl.com/G2yC1
Posts Media Videos Starter Packs
Pinned
🆕 @cochrane.org Review update 🆕

Pharmacotherapy for mild hypertension www.cochranelibrary.com/cdsr/doi/10....

In ppl w/ mildly elevated blood pressure (BP) w/out cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD

#SystematicReview
Pharmacotherapy for mild hypertension - Wang, D - 2025 | Cochrane Library
Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.
www.cochranelibrary.com
🚨ICYMI - Updated Cochrane #SystematicReview:

Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...

"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"

#CochraneEvidence #bloodpressure #deprescribing
🆕Review update🆕

Pharmacotherapy for mild #hypertension cochranelibrary.com/cdsr/doi/10....

In people with mildly elevated #BloodPressure (BP) without cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD

#SystematicReview
🆕 @cochrane.org Review update 🆕

Pharmacotherapy for mild hypertension www.cochranelibrary.com/cdsr/doi/10....

In ppl w/ mildly elevated blood pressure (BP) w/out cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD

#SystematicReview
Pharmacotherapy for mild hypertension - Wang, D - 2025 | Cochrane Library
Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.
www.cochranelibrary.com
Reposted by Cochrane Hypertension
Clearer, more consistent Cochrane reviews are coming.

From mid-November, we’re updating reporting formats to make reviews easier to use, more accessible, and more impactful.

🔗 www.cochrane.org/about-us/new...
Reposted by Cochrane Hypertension
Too good to be true? Spotting problematic trials in systematic reviews | Online
🗓️ 26 February
This interactive webinar will introduce the INSPECT-SR tool by way of application to a published clinical trial.
🔗 evidencesynthesisireland.ie/conference/w...
Webinar: Dr Jack Wilkinson - Too good to be true? Spotting problematic trials in systematic reviews
To register, CLICK HERE Systematic reviews of randomized controlled trials (RCTs) aim to include all eligible
evidencesynthesisireland.ie
Reposted by Cochrane Hypertension
Getting involved in health research reviews: a course for the public | Online
🗓️ 15 September
Are you a patient, caregiver, or member of the public interested in contributing to health research? This 6-week, self-paced course from Cochrane Ireland is for you.
🔗 www.eventbrite.ie/e/getting-in...
Getting Involved in Health Research Reviews: A Course for the Public
Designed for the public and helps you build the knowledge and skills to contribute to research teams conducting health research reviews.
www.eventbrite.ie
Reposted by Cochrane Hypertension
📣 We're rounding up a few dates for your diary. Discover these events being run by our global network of Cochrane Groups – a thread 🧵
ICYMI - Cochrane #SystematicReview 🎺

Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...

#CochraneEvidence #Blogshot
🚨ICYMI - Updated Cochrane #SystematicReview:

Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...

"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"

#CochraneEvidence #bloodpressure #deprescribing
Reposted by Cochrane Hypertension
🚨ICYMI - Updated Cochrane #SystematicReview:

Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...

"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"

#CochraneEvidence #bloodpressure #deprescribing
🆕 We've published a new Cochrane #SystematicReview protocol:

Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists
doi.org/10.1002/1465...
Reposted by Cochrane Hypertension
SR & MA findings: very few (<10%) clinical trials report adverse drug withdrawal event (ADWE) following #deprescribing, and reporting methods are inconsistent.
Standardizing reporting is needed to generate more robust evidence on deRXing and ADWEs: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
Reposted by Cochrane Hypertension
🚨Updated Cochrane #SystematicReview:

Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...

"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"

#CochraneEvidence #bloodpressure #deprescribing
Reposted by Cochrane Hypertension
🧵 #ExercisePrescriptions

1/5 The TI’s Dr. Josh Levin asks:
Clinicians, can you help your patients be more active? 🏃🏾‍♀️🏊🏾‍♂️ 🚶🏾‍♂️

👉🏾Watch Dr. Levin’s presentation: www.youtube.com/watch?v=G5he...

#Exercise #prescribing #ExerciseRx
Dr. Josh Levin: Exercise prescriptions - Evidence and clinical applications
YouTube video by Therapeutics Initiative
www.youtube.com
ICYMI - Cochrane #SystematicReview 🎺

Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...

#CochraneEvidence #Blogshot
🚨ICYMI - Cochrane #SystematicReview

Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...

#CochraneEvidence #Blogshot
#BestEvidence webinar recording

Debunking some of the hype in #Hypertension
ti.ubc.ca/drugevidence24

Dr. James Wright summarizes latest evidence on #antihypertensives:

⏰ chronotherapy
💊 first line tx
🎯 blood pressure targets
⚠️ treatment efficacy + safety

#drugevidence24 #meded #medsafety
Dr. James (Jim) Wright: Debunking some of the hype In hypertension
YouTube video by Therapeutics Initiative
youtu.be
🎺 Cochrane #SystematicReview 🚨

Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...

#CochraneEvidence #Blogshot